Maurizio Bonacini, MD
Hepatology · San Francisco, CANPI 1114944972
Payments from drug & device makers
Across 393 payments — averaging $3119.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$485K
- Boehringer Ingelheim$195K
- Intercept Pharmaceuticals, Inc.$153K
- AbbVie$124K
- Novartis$57K
- Intercept Pharma Europe Ltd.$55K
- plus $157K from 13 others
Across 17 payments — averaging $199.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Travere Therapeutics, Inc.$2K
- GSK$1K
What the payments were for
- Consulting fees$1,9892%
- Speaking & faculty fees$75,83086%
- Travel & lodging$6,4847%
- Food & beverage$3,7454%
- Education$370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 91 | $485,414 |
| Boehringer Ingelheim | 6 | $194,883 |
| Intercept Pharmaceuticals, Inc. | 44 | $152,806 |
| AbbVie(2 entities) | 77 | $123,965 |
| Novartis | 3 | $56,898 |
| Intercept Pharma Europe Ltd. | 5 | $54,942 |
| Gilead | 70 | $49,654 |
| Roche TCRC, Inc. | 9 | $45,358 |
| Madrigal Pharmaceuticals | 34 | $30,751 |
| Pfizer | 7 | $13,533 |
| Boehringer Ingelheim RCV GmbH & Co KG | 26 | $12,344 |
| Dova Pharmaceuticals | 3 | $3,894 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 9 | $1,173 |
| Roche Products Limited | 2 | $110 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $41 |
| Shionogi Inc | 2 | $35 |
| Theratechnologies Inc. | 1 | $31 |
| Napo Pharmaceuticals Inc | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,225,877 in reported general payments places this provider in the 90th percentile of 36 hepatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hepatology in San Francisco
- Neil MehtaSan Francisco$109K
- Monika SarkarSan Francisco$103K
- Courtney ShermanSan Francisco$206
- Gabrielle JutrasSan Francisco$123
- Tarek HassaneinCoronado$5.6M
- Edward MenaPasadena$4.9M
- Robert GishFolsom$1.9M
- Walid AyoubWest Hollywood$1.1M
- Lisa NybergSan Diego$903K
- Vinay SundaramLos Angeles$725K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.